ATI Pharmacology Proctor 2019-with 100% verified solutions-2022-2024
1.) A nurse is assessing a client who is receiving intravenous therapy. The nurse should identify which of the following ;ndings as a manifestat
...
ATI Pharmacology Proctor 2019-with 100% verified solutions-2022-2024
1.) A nurse is assessing a client who is receiving intravenous therapy. The nurse should identify which of the following ;ndings as a manifestation of =uid volume excess?
a. Decreased bowel sounds
b. Distended neck veins
c. Bilateral muscle weakness
d. Thread pulse
2.) A nurse is caring for a client who has hyponatremia and is receiving an infusion of a prescribed hypertonic solution. Which of the following ;ndings should indicate to the nurse that the treatment is eFective?
a. Absent Chvostek’s sign
b. Improved cognition
c. Decreased vomiting
d. Cardiac arrhythmias absent
3.) A nurse is teaching a client who has a new prescription for a nitroglycerin transdermal patch.
Which of the following instructions should the nurse include?
a. “Discontinue the patch if you experience a headache.”
b. “Apply a new patch if you have chest pain.”
c. “Cover the patch with dry gauze when taking a shower.”
d. “Remove the patch prior to going to bed.”
4.) A nurse is reviewing he laboratory results of a client who has a prescription for sodium polystyrene sulfonate (Kayexalate) every 6 hr. which of the following should the nurse report to the provider?
a. Creatinine 0.72 mg/dL
b. Sodium 138 mEq/L
c. Magnesium 2 mEq/L
d. Potassium 5.2 mEq/L - Hyperkalemia (serum potassium level greater than 5.0 mEq/L) increases the client risk for fatal cardiac dysrhythmias. Kayexalate is used to decrease the serum potassium level, so the PN should monitor the client's serum potassium level
A nurse is caring for a client who has tuberculosis and is taking isoniazid and rifampin. Which of the following outcomes indicates that the client is adhe
CONTINUED....
[Show More]